vs
Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $12.6M, roughly 1.3× Spero Therapeutics, Inc.). On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 4377.5%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 586.6%).
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
FVCB vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.9M | $12.6M |
| Net Profit | — | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 43.7% | — |
| Net Margin | — | 250.7% |
| Revenue YoY | 4377.5% | 24080.8% |
| Net Profit YoY | — | 250.9% |
| EPS (diluted) | $0.31 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.9M | $12.6M | ||
| Q3 25 | $416.0K | $0 | ||
| Q2 25 | $15.8M | $0 | ||
| Q1 25 | $382.0K | $12.0K | ||
| Q4 24 | $378.0K | $52.0K | ||
| Q3 24 | $412.0K | $65.0K | ||
| Q2 24 | $415.0K | $114.0K | ||
| Q1 24 | $359.0K | $140.0K |
| Q4 25 | — | $31.5M | ||
| Q3 25 | $5.6M | $-7.4M | ||
| Q2 25 | $5.7M | $-1.7M | ||
| Q1 25 | $5.2M | $-13.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $4.7M | $-17.1M | ||
| Q2 24 | $4.2M | $-17.9M | ||
| Q1 24 | $1.3M | $-12.7M |
| Q4 25 | 43.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 45.9% | — | ||
| Q1 25 | — | -122758.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -28604.6% | ||
| Q2 24 | — | -16720.2% | ||
| Q1 24 | — | -9987.1% |
| Q4 25 | — | 250.7% | ||
| Q3 25 | 1341.1% | — | ||
| Q2 25 | 36.0% | — | ||
| Q1 25 | 1352.1% | -115550.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 1133.3% | -26380.0% | ||
| Q2 24 | 1001.2% | -15668.4% | ||
| Q1 24 | 373.3% | -9049.3% |
| Q4 25 | $0.31 | $0.56 | ||
| Q3 25 | $0.31 | $-0.13 | ||
| Q2 25 | $0.31 | $-0.03 | ||
| Q1 25 | $0.28 | $-0.25 | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.25 | $-0.32 | ||
| Q2 24 | $0.23 | $-0.33 | ||
| Q1 24 | $0.07 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $253.6M | $59.0M |
| Total Assets | $2.3B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $253.6M | $59.0M | ||
| Q3 25 | $249.8M | $26.5M | ||
| Q2 25 | $243.2M | $32.8M | ||
| Q1 25 | $242.3M | $33.8M | ||
| Q4 24 | $235.4M | $46.1M | ||
| Q3 24 | $230.8M | $65.5M | ||
| Q2 24 | $226.5M | $80.5M | ||
| Q1 24 | $220.7M | $96.2M |
| Q4 25 | $2.3B | $68.9M | ||
| Q3 25 | $2.3B | $54.2M | ||
| Q2 25 | $2.2B | $62.1M | ||
| Q1 25 | $2.2B | $77.7M | ||
| Q4 24 | $2.2B | $110.5M | ||
| Q3 24 | $2.3B | $135.2M | ||
| Q2 24 | $2.3B | $149.9M | ||
| Q1 24 | $2.2B | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $-8.4M |
| Free Cash FlowOCF − Capex | $23.8M | — |
| FCF MarginFCF / Revenue | 140.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $40.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $-8.4M | ||
| Q3 25 | $7.6M | $17.4M | ||
| Q2 25 | $3.3M | $-17.7M | ||
| Q1 25 | $5.4M | $-4.0M | ||
| Q4 24 | $18.2M | $-23.4M | ||
| Q3 24 | $4.7M | $12.8M | ||
| Q2 24 | $1.6M | $-18.7M | ||
| Q1 24 | $7.2M | $5.9M |
| Q4 25 | $23.8M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $18.1M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | 140.7% | — | ||
| Q3 25 | 1818.0% | — | ||
| Q2 25 | 20.8% | — | ||
| Q1 25 | 1413.6% | — | ||
| Q4 24 | 4786.0% | — | ||
| Q3 24 | 1121.8% | — | ||
| Q2 24 | 361.2% | — | ||
| Q1 24 | 1988.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
